Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
ByHeart Formula Recall Lawsuit Parents are now filing ByHeart recall lawsuits alleging that contaminated infant formula caused botulism and other serious illnesses after the company failed to prevent or warn about dangerous manufacturing lapses.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Direct Filing of Hair Relaxer Lawsuits in Federal MDL To Be Proposed By Parties Parties have until March 31 to submit a proposed order that would allow plaintiffs to file new hair relaxer lawsuits directly in the MDL. March 14, 2023 Irvin Jackson Add Your Comments The U.S. District Judge presiding over the coordinated pretrial proceedings in all federal hair relaxer lawsuits has called for parties to submit a proposed order by the end of March, which would create a streamlined process for filing new complaints over uterine cancer, endometrial cancer, ovarian cancer and other ailments caused by use of chemical straighteners. Over the past few months, a steadily growing number of Dark & Lovely lawsuits, Just for Me lawsuits and other claims have been brought against the makers of popular hair perm kits commonly used by Black women, alleging that inadequate warnings have been provided about the toxic side effects of endocrine disrupting chemicals in the products. As hair relaxer lawyers continue to investigate and review claims, it is expected that the size and scope of the litigation will increase rapidly throughout 2023, and it is ultimately expected that thousands of women will file a lawsuit. HAIR RELAXER COMPENSATION Did you or a loved one use hair relaxer products? Uterine cancer, endometrial cancer and ovarian cancer may be caused by chemicals in hair relaxer. See if you are eligible for benefits. Learn More SEE IF YOU QUALIFY FOR COMPENSATION HAIR RELAXER COMPENSATION Did you or a loved one use hair relaxer products? Uterine cancer, endometrial cancer and ovarian cancer may be caused by chemicals in hair relaxer. See if you are eligible for benefits. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Given common questions of fact and law involved in each of the claims, the U.S. Judicial Panel on Multidistrict Litigation decided last month to consolidate and centralize all hair relaxer lawsuits as part of an MDL, or multidistrict litigation, and appointed U.S. District Judge Mary M. Rowland to preside over all discovery and pretrial proceedings out of the Northern District of Illinois. As part of the coordinated management of the litigation, it is expected that Judge Rowland will establish a bellwether process, where small groups of representative injury claims will go through case-specific discovery and be prepared for early trial dates, to help gauge how juries are likely to respond to certain evidence and testimony that will be repeated throughout the litigation. Judge Calls for Hair Relaxer Lawsuit Direct Filing Order In complex product liability lawsuits, where large numbers of individuals are pursuing similar claims and allegations, it is common for the Court to approve a Master and Short Form Complaint, where plaintiffs can then file future lawsuits through an abbreviated form, where they adopt allegations that are relevant to their specific claim. At a case management conference held earlier this month, Judge Rowland asked the parties to work together to draft a direct filing order, which is the first step in the process of creating a Master and Short Form Complaint, allowing plaintiffs to file lawsuits directly with the MDL court instead of having to wait to have them transferred from various different U.S. District Courts nationwide. In a joint status report (PDF) submitted on March 10, plaintiffs indicate that they will provide a draft Direct Filing Order to defendants by March 13. The parties will then confer and submit either an agreed-to proposed order by March 31, 2023, or they will each file respective proposals if an agreement can not be reached about the streamlined process for bringing new hair relaxer lawsuits. In complex product liability cases, where a large number of claims are filed throughout the federal court system by individuals who suffered similar injuries as a result of the same or similar products, it is common for the federal court system to centralize the litigation for pretrial proceedings. The use of a direct filing order to create a Master and Short Form complaint streamlines the filing process, reducing delays in pretrial proceedings and allowing the Court to rule on standardized allegations and claims that apply to a number of claims. Following the MDL proceedings and any early bellwether trials scheduled by Judge Rowland, if the parties fail to negotiate hair relaxer settlements for individuals diagnosed with cancer and other injuries, the Court may later remand each individual lawsuit directly filed in the MDL back to the U.S. District Court where it would have originated for a separate trial. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Endocrine Disruptors, Endometriosis, Hair Relaxer, Hair Straighteners, L'Oreal, Perm, Phthalates, Uterine Cancer, Uterine Fibroids Find Out If You Qualify for Hair Relaxer Compensation More Hair Relaxer Lawsuit Stories Hair Relaxer Manufacturers Push for Evidence Many Plaintiffs Did Not Likely Keep December 10, 2025 Hair Relaxer Lawsuit MDL Status Hearings Scheduled Throughout 2026 November 13, 2025 Update on Hair Relaxer Lawsuit Status To Be Provided to Court at MDL Hearing November 5, 2025 1 Comments Leslie March 14, 2023 Hello my name is Leslie and I have always used the relaxers I stopped a few years ago because my hair had fallen out and I also had a hysterectomy done at a young age CommentsThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: today) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025) Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL (Posted: yesterday) All Ozempic and Wegovy vision loss lawsuits have been consolidated before the same federal judge overseeing related claims alleging stomach paralysis linked to the medications. MORE ABOUT: OZEMPIC LAWSUITOzempic, Mounjaro Side Effects May Increase Risk of Cough: Study (12/03/2025)Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (11/26/2025)Ozempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025) Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (Posted: 2 days ago) The FDA has approved an update to the Depo-Provera drug label to include a warning of the risks of meningioma. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025)Depo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (12/01/2025)
Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (Posted: today) An Illinois woman diagnosed with stage IV cutaneous T-cell lymphoma (CTCL) after two years of Dupixent injections has filed a lawsuit against the drug manufacturers. MORE ABOUT: DUPIXENT LAWSUITLawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)
Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL (Posted: yesterday) All Ozempic and Wegovy vision loss lawsuits have been consolidated before the same federal judge overseeing related claims alleging stomach paralysis linked to the medications. MORE ABOUT: OZEMPIC LAWSUITOzempic, Mounjaro Side Effects May Increase Risk of Cough: Study (12/03/2025)Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (11/26/2025)Ozempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)
Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (Posted: 2 days ago) The FDA has approved an update to the Depo-Provera drug label to include a warning of the risks of meningioma. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (12/08/2025)Depo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (12/01/2025)